Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis.

Arellano, Felix M; Wentworth, Charles E; Arana, Alejandro; Fernández, Carlos; Paul, Carle F

Arellano, Felix M; Wentworth, Charles E; Arana, Alejandro; Fernández, Carlos; Paul, Carle F.

Affiliation

Arellano FM; Risk Management Resources, 726 Route 202 South, Suite 320-361, Bridgewater, New Jersey, USA. arellano@riskmr.com

J Invest Dermatol ; 127(4): 808-16, 2007 Apr.

Article in En | MEDLINE | ID: mdl-17096020

Subject(s)

Calcineurin Inhibitors; Dermatitis, Atopic/drug therapy; Lymphoma/chemically induced; Steroids/adverse effects; Administration, Topical; Adolescent; Adult; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Databases, Factual; Dermatitis, Atopic/complications; Dermatitis, Atopic/physiopathology; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Lymphoma/complications; Male; Middle Aged; Risk Assessment; Severity of Illness Index; Steroids/administration & dosage; Steroids/therapeutic use; Tacrolimus/adverse effects; Tacrolimus/analogs & derivatives; Tacrolimus/therapeutic use

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Steroids / Dermatitis, Atopic / Calcineurin Inhibitors / Lymphoma Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged / Newborn Language: En Journal: J Invest Dermatol Year: 2007 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links